Schroder Investment Management Group Raises Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Schroder Investment Management Group raised its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 742,571 shares of the company’s stock after buying an additional 18,623 shares during the quarter. Schroder Investment Management Group owned about 0.28% of Ryan Specialty worth $47,317,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in Ryan Specialty during the fourth quarter worth about $94,484,000. Norges Bank bought a new stake in shares of Ryan Specialty in the 4th quarter worth approximately $78,358,000. Principal Financial Group Inc. grew its stake in shares of Ryan Specialty by 115.2% in the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company’s stock worth $117,619,000 after buying an additional 981,505 shares during the last quarter. Vanguard Group Inc. increased its position in Ryan Specialty by 5.7% during the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company’s stock valued at $633,933,000 after buying an additional 529,631 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock valued at $30,504,000 after buying an additional 238,064 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.4 %

Ryan Specialty stock opened at $73.96 on Tuesday. The business has a 50-day simple moving average of $68.89 and a two-hundred day simple moving average of $68.39. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $19.37 billion, a P/E ratio of 107.18, a P/E/G ratio of 1.19 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last announced its earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The business had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a yield of 0.65%. Ryan Specialty’s payout ratio is 69.57%.

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total value of $2,309,650.00. Following the completion of the transaction, the director now directly owns 35,609 shares in the company, valued at $2,349,837.91. This represents a 49.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the firm’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 241,360 shares of company stock valued at $16,006,428. Company insiders own 11.10% of the company’s stock.

Wall Street Analysts Forecast Growth

RYAN has been the subject of several analyst reports. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target for the company. UBS Group raised their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. Wells Fargo & Company upped their target price on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. Royal Bank of Canada decreased their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a report on Friday, February 21st. Finally, Keefe, Bruyette & Woods cut their target price on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Ryan Specialty currently has a consensus rating of “Hold” and a consensus target price of $75.27.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.